Your account is not claimed yet. You can sign up with ORCID to claim your account.

Matti Kankainen (M Kankainen)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 13

Top Venues

Leukemia

Cancers

Nature communications

Molecular genetics & genomic medicine

University of Helsinki

University of Helsinki (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Helsinki Mar 1o 2019

Finland

Bioinformatics team lead (group Mustjoki) :: Hematology Research Unit Helsinki

Education History

University of Helsinki Jun 1o 2003 - Jun 1o 2015

Finland

PHD :: Department of Genetics

Publications

Alisa Olkinuora, Taina T Nieminen, Suvi P M Douglas, Anni Kauppinen, Mika Kontro, Juho Väänänen, Matti Kankainen, Ari Ristimäki, Markus Mäkinen, Päivi Lahermo, Caroline A Heckman, Janna Saarela, Milla K Ahola, Anna Lepistö, Heikki Järvinen, Jukka-Pekka Mecklin, Outi Kilpivaara, Ulla Wartiovaara-Kautto, Kimmo Porkka, Päivi Peltomäki
Identification of DHX40 as a candidate susceptibility gene for colorectal and hematological neoplasia. Leukemia (2023)
Moon Hee Lee, Petrus Järvinen, Harry Nísen, Oscar Brück, Mette Ilander, Ilona Uski, Jason Theodoropoulos, Matti Kankainen, Tuomas Mirtti, Mohamed El Missiry, Anna Kreutzman
T and NK cell abundance defines two distinct subgroups of renal cell carcinoma. Oncoimmunology 11 (1) (2022)
Shady Adnan-Awad, Oscar Brück, Naranie Shanmuganathan, Timo Jarvinen, Hanna Lähteenmäki, Jay Klievink, Hazem Ibrahim, Soili Kytölä, Perttu Koskenvesa, Timothy P Hughes, Susan Branford, Matti Kankainen, Mohamed El Missiry
Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation. Blood cancer journal 12 (4) (2022)
Liisa Viitasalo, Kaisa Kettunen, Matti Kankainen, Elina H Niemelä, Kirsi Kiiski
A novel partial de novo duplication of JARID2 gene causing a neurodevelopmental phenotype. Molecular genetics & genomic medicine 10 (11) (2022)
Jani Huuhtanen, Dipabarna Bhattacharya, Tapio Lönnberg, Matti Kankainen, Cassandra Kerr, Jason Theodoropoulos, Hanna L M Rajala, Carmelo Gurnari, Tiina Kasanen, Till Braun, Antonella Teramo, Renato Zambello, Marco Herling, Fumihiro Kawakami, Toru Kawakami, Marko Salmi, Thomas Loughran, Jaroslaw P Maciejewski, Harri Lähdesmäki, Tiina Kelkka, Mohamed El Missiry
Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8 + T-cell large granular lymphocytic leukemia. Nature communications 13 (1) (2022)
Ashwini Kumar, Sadiksha Adhikari, Matti Kankainen, Caroline A Heckman
Comparison of Structural and Short Variants Detected by Linked-Read and Whole-Exome Sequencing in Multiple Myeloma. Cancers 13 (6) (2021)
Daehong Kim, Giljun Park, Jani Huuhtanen, Bishwa R Ghimire, Hanna Rajala, Richard Moriggl, Wing C Chan, Matti Kankainen, Mikko Myllymäki, Mohamed El Missiry
STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylation. Leukemia 35 (12) (2021)
Emilia Wiechec, Mustafa Magan, Natasa Matic, Anna Ansell-Schultz, Matti Kankainen, Outi Monni, Ann-Charlotte Johansson, Karin Roberg
Cancer-Associated Fibroblasts Modulate Transcriptional Signatures Involved in Proliferation, Differentiation and Metastasis in Head and Neck Squamous Cell Carcinoma. Cancers 13 (13) (2021)
Sofie A Lundgren, Mikko A I Keränen, Matti Kankainen, Jani Huuhtanen, Gunilla Walldin, Cassandra M Kerr, Michael Clemente, Freja Ebeling, Hanna Rajala, Oscar Brück, Harri Lähdesmäki, Sari Hannula, Tiina Hannunen, Pekka Ellonen, Neal S Young, Seishi Ogawa, Jaroslaw P Maciejewski, Eva Hellström-Lindberg, Mohamed El Missiry
Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia. Leukemia 35 (5) (2021)
Dan J Woodcock, E Riabchenko, S Taavitsainen, Matti Kankainen, Gunes Gundem, Daniel S Brewer, P Ellonen, M Lepistö, Y A Golubeva, Andrew C Warner, T Tolonen, J Jasu, W B Isaacs, M R Emmert-Buck, M Nykter, Tapio Visakorpi, G Steven Bova, David C Wedge
Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy. Nature communications 11 (1) (2020)
Dominik Eichin, Alberto Pessia, Akira Takeda, Joni Laakkonen, Lydia Bellmann, Matti Kankainen, Beat A Imhof, Patrizia Stoitzner, Jing Tang, Marko Salmi, Sirpa Jalkanen
CD73 contributes to anti-inflammatory properties of afferent lymphatic endothelial cells in humans and mice. European journal of immunology 51 (1) (2020)
Shady Adnan-Awad, Olli Dufva, Aleksandr Ianevski, Bishwa R Ghimire, Jan Koski, Pilvi Maliniemi, Daniel Thomson, Andreas Schreiber, Caroline A Heckman, Perttu Koskenvesa, Matti Korhonen, Kimmo Porkka, Susan Branford, Tero Aittokallio, Matti Kankainen, Mohamed El Missiry
RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses. Leukemia 35 (4) (2020)
Shady Adnan-Awad, Daehong Kim, Helena Hohtari, Komal Kumar Javarappa, Tania Brandstoetter, Isabella Mayer, Swapnil Potdar, Caroline A Heckman, Soili Kytölä, Kimmo Porkka, Eszter Doma, Veronika Sexl, Matti Kankainen, Mohamed El Missiry
Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets. Leukemia 35 (7) (2020)

Matti Kankainen.css-eqlu8i{font-size:small;padding-left:4px;} (M Kankainen)

Publication Activity (10 Years)

Top Topics

Top Venues

Matti Kankainen (M Kankainen)